BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23082007)

  • 1. PROKR2 and PROK2 mutations cause isolated congenital anosmia without gonadotropic deficiency.
    Moya-Plana A; Villanueva C; Laccourreye O; Bonfils P; de Roux N
    Eur J Endocrinol; 2013 Jan; 168(1):31-7. PubMed ID: 23082007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallmann syndrome caused by mutations in the PROK2 and PROKR2 genes: pathophysiology and genotype-phenotype correlations.
    Sarfati J; Dodé C; Young J
    Front Horm Res; 2010; 39():121-132. PubMed ID: 20389090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome.
    Abreu AP; Trarbach EB; de Castro M; Frade Costa EM; Versiani B; Matias Baptista MT; Garmes HM; Mendonca BB; Latronico AC
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4113-8. PubMed ID: 18682503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.
    Hardelin JP; Dodé C
    Sex Dev; 2008; 2(4-5):181-93. PubMed ID: 18987492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.
    Cole LW; Sidis Y; Zhang C; Quinton R; Plummer L; Pignatelli D; Hughes VA; Dwyer AA; Raivio T; Hayes FJ; Seminara SB; Huot C; Alos N; Speiser P; Takeshita A; Van Vliet G; Pearce S; Crowley WF; Zhou QY; Pitteloud N
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3551-9. PubMed ID: 18559922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1.
    Canto P; Munguía P; Söderlund D; Castro JJ; Méndez JP
    J Androl; 2009; 30(1):41-5. PubMed ID: 18723471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Kallmann syndrome: a historical [corrected] clinical and molecular review].
    Ribeiro RS; Abucham J
    Arq Bras Endocrinol Metabol; 2008 Feb; 52(1):8-17. PubMed ID: 18345392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypogonadotropic hypogonadism: new aspects in the regulation of hypothalamic-pituitary-gonadal axis].
    Brioude F; Bouvattier CE; Lombès M
    Ann Endocrinol (Paris); 2010 Sep; 71 Suppl 1():S33-41. PubMed ID: 21237329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in PROKR2, but not PROK2, are associated with hypopituitarism and septo-optic dysplasia.
    McCabe MJ; Gaston-Massuet C; Gregory LC; Alatzoglou KS; Tziaferi V; Sbai O; Rondard P; Masumoto KH; Nagano M; Shigeyoshi Y; Pfeifer M; Hulse T; Buchanan CR; Pitteloud N; Martinez-Barbera JP; Dattani MT
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E547-57. PubMed ID: 23386640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.
    Dodé C; Teixeira L; Levilliers J; Fouveaut C; Bouchard P; Kottler ML; Lespinasse J; Lienhardt-Roussie A; Mathieu M; Moerman A; Morgan G; Murat A; Toublanc JE; Wolczynski S; Delpech M; Petit C; Young J; Hardelin JP
    PLoS Genet; 2006 Oct; 2(10):e175. PubMed ID: 17054399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes.
    Sarfati J; Guiochon-Mantel A; Rondard P; Arnulf I; Garcia-Piñero A; Wolczynski S; Brailly-Tabard S; Bidet M; Ramos-Arroyo M; Mathieu M; Lienhardt-Roussie A; Morgan G; Turki Z; Bremont C; Lespinasse J; Du Boullay H; Chabbert-Buffet N; Jacquemont S; Reach G; De Talence N; Tonella P; Conrad B; Despert F; Delobel B; Brue T; Bouvattier C; Cabrol S; Pugeat M; Murat A; Bouchard P; Hardelin JP; Dodé C; Young J
    J Clin Endocrinol Metab; 2010 Feb; 95(2):659-69. PubMed ID: 20022991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Greater prevalence of PROKR2 mutations in Kallmann syndrome patients from the Maghreb than in European patients.
    Sarfati J; Fouveaut C; Leroy C; Jeanpierre M; Hardelin JP; Dodé C
    Eur J Endocrinol; 2013 Dec; 169(6):805-9. PubMed ID: 24031091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kallmann syndrome in women: from genes to diagnosis and treatment.
    Meczekalski B; Podfigurna-Stopa A; Smolarczyk R; Katulski K; Genazzani AR
    Gynecol Endocrinol; 2013 Apr; 29(4):296-300. PubMed ID: 23368665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.
    Pitteloud N; Zhang C; Pignatelli D; Li JD; Raivio T; Cole LW; Plummer L; Jacobson-Dickman EE; Mellon PL; Zhou QY; Crowley WF
    Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17447-52. PubMed ID: 17959774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital hypogonadotropic hypogonadism in females: clinical spectrum, evaluation and genetics.
    Bry-Gauillard H; Trabado S; Bouligand J; Sarfati J; Francou B; Salenave S; Chanson P; Brailly-Tabard S; Guiochon-Mantel A; Young J
    Ann Endocrinol (Paris); 2010 May; 71(3):158-62. PubMed ID: 20363464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biallelic mutations in the prokineticin-2 gene in two sporadic cases of Kallmann syndrome.
    Leroy C; Fouveaut C; Leclercq S; Jacquemont S; Boullay HD; Lespinasse J; Delpech M; Dupont JM; Hardelin JP; Dodé C
    Eur J Hum Genet; 2008 Jul; 16(7):865-8. PubMed ID: 18285834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization.
    Quinton R; Duke VM; Robertson A; Kirk JM; Matfin G; de Zoysa PA; Azcona C; MacColl GS; Jacobs HS; Conway GS; Besser M; Stanhope RG; Bouloux PM
    Clin Endocrinol (Oxf); 2001 Aug; 55(2):163-74. PubMed ID: 11531922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analyses in pedigrees and sporadic cases of ethnic Han Chinese Kallmann syndrome patients.
    Gu WJ; Zhang Q; Wang YQ; Yang GQ; Hong TP; Zhu DL; Yang JK; Ning G; Jin N; Chen K; Zang L; Wang AP; Du J; Wang XL; Yang LJ; Ba JM; Lv ZH; Dou JT; Mu YM
    Exp Biol Med (Maywood); 2015 Nov; 240(11):1480-9. PubMed ID: 26031747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PROK2/PROKR2 signaling pathway is required for the migration of most olfactory bulb interneurons.
    Wen Y; Zhang Z; Li Z; Liu G; Tao G; Song X; Xu Z; Shang Z; Guo T; Su Z; Chen H; You Y; Li J; Yang Z
    J Comp Neurol; 2019 Dec; 527(18):2931-2947. PubMed ID: 31132148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics.
    Oliveira LM; Seminara SB; Beranova M; Hayes FJ; Valkenburgh SB; Schipani E; Costa EM; Latronico AC; Crowley WF; Vallejo M
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1532-8. PubMed ID: 11297579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.